QUEST DIAGNOSTICS INC News
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
see moreQUEST DIAGNOSTICS INC Market News
9d
Quest Diagnostics to Offer FDA‑Cleared Roche pTau217 Alzheimer’s Test, Expanding DGX’s Advanced Diagnostics Portfolio
- Quest Diagnostics (DGX) will begin offering Roche’s FDA‑cleared pTau217 blood test for Alzheimer’s pathology, augmenting its AD‑Detect® offerings.
23d
Quest Diagnostics Declares $0.86 Quarterly Dividend Despite Quiet August
Quest Diagnostics (NYSE: DGX) has declared a $0.86 per share quarterly dividend amid minimal fresh developments in the past week.
12 Aug at 17:40
Quest Diagnostics Highlights Growing Community Health Initiatives Amid Financial Landscape
Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, has recently been involved in several significant activities that may influence its stock performance.
28 Jul at 11:23
Quest Diagnostics' Q2 2026 Earnings Surpass Expectations; Full-Year Guidance Raised
Quest Diagnostics reports strong Q2 2026 earnings, raises full-year guidance.
26 Jul at 18:09
Quest Diagnostics Reports Strong Q2 2026 Results, Raises Full-Year Guidance
Quest Diagnostics posts robust Q2 2026 earnings, boosts annual outlook.